How many patents does
Jiangsu Hengrui Medicine Company have?

patents
1,686
families
251
granted
306
applications
1,380
CN
344
WO
182
EP
167
US
140
KR
82
JP
68
RoW
703

Buy the report

The report contains ten-year analysis with the following sections

  • patent filing analysis
  • worldwide filing analysis
  • patent family analysis
  • application analysis
  • granted analysis
  • classification analysis
  • citation analysis

contact us for pricing

  • VAT will apply to UK companies
  • EU companies must supply their VAT number

Check out our sample pages

advert_20200321_samples.png

Find companies to compare

Many companies now available

companies
12,000+
patents
42 million
patent families
23 million

Search to find companies of interest

read summary of their published patent

the following tables are just extracts from the report

the company report contains more information

Jiangsu Hengrui Medicine Company
Top ten assignees appearing on patents

Jiangsu Hengrui Medicine Company
The top ten patent families are

Title of patent family
(most common patent title)
Family
members
Filing
year
pyrrole six-membered heteroaryl ring derivative, preparation method therefor, and medici… 🛈 33 2011
6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceut… 🛈 31 2009
liposome of irinotecan or its hydrochloride and preparation method thereof 30 2009
phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use ther… 🛈 30 2010
salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use there… 🛈 28 2009
crystalline form i of tyrosine kinase inhibitor dimaleate and preparation methods thereof 28 2012
tetrahydro-imidazo[1,5-a]pyrazine derivatives, preparation methods and medical uses ther… 🛈 26 2007
bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical us… 🛈 24 2008
salts of methyl (r)-7-[3-amino-4-(2,4,5-trifluoro-phenyl)-butyryl]-3-trifluoromethyl-5,6… 🛈 24 2009
dihydropteridinone derivatives, preparation process and pharmaceutical use thereof 24 2009